Assenagon Asset Management S.A. Arvinas, Inc. Transaction History
Assenagon Asset Management S.A.
- $65.1 Billion
- Q3 2025
A detailed history of Assenagon Asset Management S.A. transactions in Arvinas, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 39,395 shares of ARVN stock, worth $391,192. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,395
Previous 50,366
21.78%
Holding current value
$391,192
Previous $370,000
9.46%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
68.4MCall Options Held
2.99MPut Options Held
534K-
Vanguard Group Inc Valley Forge, PA9.39MShares$93.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$62.1 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.67MShares$36.5 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA3.3MShares$32.8 Million3.14% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.15MShares$21.4 Million0.01% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $528M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...